Andreas Lind

3.2k total citations
32 papers, 383 citations indexed

About

Andreas Lind is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Andreas Lind has authored 32 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 11 papers in Immunology and 9 papers in Epidemiology. Recurrent topics in Andreas Lind's work include SARS-CoV-2 and COVID-19 Research (10 papers), HIV Research and Treatment (8 papers) and COVID-19 Clinical Research Studies (8 papers). Andreas Lind is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), HIV Research and Treatment (8 papers) and COVID-19 Clinical Research Studies (8 papers). Andreas Lind collaborates with scholars based in Norway, United States and Sweden. Andreas Lind's co-authors include Dag Kvale, Susanne Dudman, Marius Trøseid, Anne Ma Dyrhol‐Riise, Frank Olav Pettersen, Fredrik Müller, Per Kristian Knudsen, Jan Cato Holter, Birgitte Stiksrud and Birger Sørensen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Virology.

In The Last Decade

Andreas Lind

31 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Lind Norway 11 205 91 83 81 72 32 383
Jesper Damsgaard Gunst Denmark 10 268 1.3× 163 1.8× 70 0.8× 107 1.3× 82 1.1× 27 467
Saeid Najafi Fard Italy 14 347 1.7× 89 1.0× 69 0.8× 87 1.1× 148 2.1× 28 555
Simone Vasilij Benatti Italy 7 173 0.8× 121 1.3× 86 1.0× 20 0.2× 43 0.6× 13 322
Sophie Seang France 9 144 0.7× 96 1.1× 92 1.1× 37 0.5× 23 0.3× 31 307
Andrea Mastrángelo Italy 10 170 0.8× 35 0.4× 100 1.2× 42 0.5× 60 0.8× 21 380
Raquel Ron Spain 10 148 0.7× 73 0.8× 61 0.7× 25 0.3× 64 0.9× 24 261
Alexandre Carvalho Portugal 5 189 0.9× 94 1.0× 16 0.2× 48 0.6× 57 0.8× 13 331
Jovan Ranin Serbia 12 196 1.0× 31 0.3× 124 1.5× 27 0.3× 66 0.9× 49 469
Javier García‐Abellán Spain 13 355 1.7× 233 2.6× 33 0.4× 26 0.3× 40 0.6× 33 475
Shashikala Sangle India 9 195 1.0× 112 1.2× 10 0.1× 37 0.5× 37 0.5× 23 339

Countries citing papers authored by Andreas Lind

Since Specialization
Citations

This map shows the geographic impact of Andreas Lind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Lind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Lind more than expected).

Fields of papers citing papers by Andreas Lind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Lind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Lind. The network helps show where Andreas Lind may publish in the future.

Co-authorship network of co-authors of Andreas Lind

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Lind. A scholar is included among the top collaborators of Andreas Lind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Lind. Andreas Lind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dudman, Susanne, et al.. (2024). Trends in the enterovirus surveillance in Oslo, Norway before and during the COVID-19 pandemic. SHILAP Revista de lepidopterología. 3. 2 indexed citations
2.
Grégoire, V., Julien Labreuche, Hélène Béhal, et al.. (2024). 165P Consistency analysis of c-Met protein expression over time in patients with non-squamous non-small cell lung cancer. Annals of Oncology. 35. S282–S282. 1 indexed citations
3.
Syberfeldt, Anna, Dan Lämkull, Dan Högberg, Lars Hanson, & Andreas Lind. (2023). Extending and demonstrating an engineering communication framework utilising the digital twin concept in a context of factory layouts. International Journal of Services Operations and Informatics. 12(3). 1–1. 2 indexed citations
4.
Federico, Lorenzo, Tor Henrik Anderson Tvedt, Viktoriia Chaban, et al.. (2023). Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study. Frontiers in Immunology. 14. 1210899–1210899. 3 indexed citations
5.
Lee, Yunsung, Karl Trygve Kalleberg, Andreas Lind, et al.. (2022). EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection. Scientific Reports. 12(1). 11478–11478. 17 indexed citations
6.
Gohli, Jostein, et al.. (2022). Dispersion of SARS‐CoV‐2 in air surrounding COVID‐19‐infected individuals with mild symptoms. Indoor Air. 32(2). e13001–e13001. 4 indexed citations
7.
Dahl, Tuva B., Kuan Yang, Trine Ranheim, et al.. (2021). Critical COVID‐19 is associated with distinct leukocyte phenotypes and transcriptome patterns. Journal of Internal Medicine. 290(3). 677–692. 17 indexed citations
8.
Søraas, Arne, Karl Trygve Kalleberg, John Arne Dahl, et al.. (2021). Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study. PLoS ONE. 16(8). e0256142–e0256142. 32 indexed citations
9.
Knudsen, Per Kristian, et al.. (2021). The incidence of infectious diseases and viruses other than SARS-CoV-2 amongst hospitalised children in Oslo, Norway during the Covid-19 pandemic 2020–2021. SHILAP Revista de lepidopterología. 2(1). 100060–100060. 24 indexed citations
10.
Norheim, Arne Johan, Einar Kristian Borud, Andreas Lind, et al.. (2021). Pre-screening and preventive quarantine likely explains the low SARS-CoV-2 prevalence among Norwegian conscripts. Scandinavian Journal of Primary Health Care. 39(1). 31–34. 1 indexed citations
11.
Lind, Andreas, Elisabeth Toverud Landaas, Cathrine Fladeby, et al.. (2021). Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory. Journal of Clinical Virology. 141. 104906–104906. 18 indexed citations
12.
Aaløkken, Trond Mogens, et al.. (2020). En mann i 90-årene med feber og tørrhoste. Tidsskrift for Den norske legeforening. 140(6). 4 indexed citations
13.
Prebensen, Christian, Andreas Lind, Anne Ma Dyrhol‐Riise, & Dag Kvale. (2016). Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy. PLoS ONE. 11(4). e0153849–e0153849. 2 indexed citations
14.
Prebensen, Christian, Thor Ueland, Annika E. Michelsen, et al.. (2015). High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 69(4). 395–402. 6 indexed citations
15.
Lind, Andreas, Carol Holm‐Hansen, Inger Lise Haugen, et al.. (2014). Intranasal Administration of a Therapeutic HIV Vaccine (Vacc-4x) Induces Dose-Dependent Systemic and Mucosal Immune Responses in a Randomized Controlled Trial. PLoS ONE. 9(11). e112556–e112556. 23 indexed citations
16.
17.
Lind, Andreas, Maja A. Sommerfelt, Jens Holmberg, et al.. (2013). Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanisms. Vaccine. 31(41). 4611–4618. 9 indexed citations
18.
Lind, Andreas, Maja A. Sommerfelt, Jens Holmberg, et al.. (2012). Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years. Scandinavian Journal of Infectious Diseases. 44(8). 566–572. 9 indexed citations
19.
Pettersen, Frank Olav, Anders Erik Astrup Dahm, Ingeborg S. Aaberge, et al.. (2011). An Exploratory Trial of Cyclooxygenase Type 2 Inhibitor in HIV-1 Infection: Downregulated Immune Activation and Improved T Cell-Dependent Vaccine Responses. Journal of Virology. 85(13). 6557–6566. 53 indexed citations
20.
Lind, Andreas, et al.. (1986). Clinical and pharmacokinetic studies on enoxacin in ear, nose and throat infections. Infection. 14(S3). S211–S212. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jesper Damsgaard Gunst Breakdown of academic impact, for papers by Saeid Najafi Fard Breakdown of academic impact, for papers by Simone Vasilij Benatti Breakdown of academic impact, for papers by Sophie Seang Breakdown of academic impact, for papers by Andrea Mastrángelo Breakdown of academic impact, for papers by Raquel Ron Breakdown of academic impact, for papers by Alexandre Carvalho Breakdown of academic impact, for papers by Jovan Ranin Breakdown of academic impact, for papers by Javier García‐Abellán Breakdown of academic impact, for papers by Shashikala Sangle
Rankless by CCL
2026